Full Text View
Tabular View
No Study Results Posted
Related Studies
Glycine and D-Cycloserine in Schizophrenia
This study has been completed.
Study NCT00000372   Information provided by National Institute of Mental Health (NIMH)
First Received: November 2, 1999   Last Updated: December 6, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
D-cycloserine
Glycine
Clozapine
Additional drug interventions recognized in this trial
Cycloserine
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Antibiotics, Antitubercular
Antimetabolites
Antipsychotic Agents
Antitubercular Agents
Central Nervous System Agents
Central Nervous System Depressants
GABA Agents
GABA Antagonists
Glycine Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Renal Agents
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services